Related Articles
Combined treatment of dendritoma vaccine and low-dose interleukin-2 in stage IV renal cell carcinoma patients induced clinical response: A pilot study
SOCS1 silencing can break high-dose dendritic cell immunotherapy-induced immune tolerance
Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: A comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells
Vaccination against human cancers (review).
Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial